Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antibiotics >  Cephalosporins Drugs >  Cefroxadine

Cefroxadine

Basic information Safety Supplier Related

Cefroxadine Basic information

Product Name:
Cefroxadine
Synonyms:
  • cxd
  • CEFROXADINE
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methoxy-8-oxo-, [6R-[6α,7β(R*)]]-
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methoxy-8-oxo-, (6R,7R)-
  • Oraspor
  • (6R,7R)-7-[[(2R)-2-Amino-2-(1-cyclohexa-1,4-dienyl)acetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[[(R)-Amino(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • C12979
CAS:
51762-05-1
MF:
C16H19N3O5S
MW:
365.4
EINECS:
257-391-8
Mol File:
51762-05-1.mol
More
Less

Cefroxadine Chemical Properties

Melting point:
170° (dec)
alpha 
D20 +87° (c = 1.093 in 0.1N HCl)
Boiling point:
251°C (rough estimate)
Density 
1.3163 (rough estimate)
refractive index 
1.6390 (estimate)
pka
pKa 3.30±0.02(H2O t=35.0 I=0.00)(Approximate)
More
Less

Safety Information

Toxicity
LD50 in mice (mg/kg): >6000 orally; 7090 i.p. (Scartazzini, Bickel, 1978)
More
Less

Cefroxadine Usage And Synthesis

Originator

Oraspor,Ciba Geigy,Switz.,1981

Uses

Antibacterial.

Manufacturing Process

A suspension of 30.64 g (0.2 mol) of D-α-amino-α-(1,4-cyclohexadienyl)- acetic acid in 600 ml of methylene chloride is cooled under a stream of argon to 6°C, whereupon hydrogen chloride is passed in for about 30 minutes until the mixture is saturated. Phosphorpentachloride (62.4 g, 0.3 mol) is added in two portions. The mixture is stirred for 2 hours at 6°C to 8°C. The colorless precipitate is filtered off under nitrogen and exclusion of moisture, washed with methylene chloride and dried for 18 hours at 0.05 mm Hg at room temperature to give D-α-amino-α-(1,4-cyclohexadienyl)-acetylchloride hydrochloride in form of colorless crystals.
A suspension of 37.3 g (0.1 mol) of 7β-amino-3-methoxy-3-cephem-4- carboxylic acid hydrochloride dioxanate in 500 ml methylene chloride is stirred for 15 minutes at room temparature under an argon atmosphere and treated with 57.2 ml (0.23 mol) of bis-(trimethylsilyl)acetamide. After 45 minutes the faintly yellow slightly turbid solution is cooled to 0°C and treated within 10 minutes with 31.29 (0.15 mol) of D-α-amino-α-(1,4-cyclohexadienyl)-acetyl chloride hydrochloride. Thirty minutes thereafter 15 ml (about 0.21 mol) of propylene oxide is added and the mixture is further stirred for 1 hour at 0°C: A cooled mixture of 20 ml of absolute methanol in 200 ml of methylene chloride is added within 30 minutes, after another 30 minutes the precipitate is filtered off under exclusion of moisture, washed with methylene chloride and dried under reduced pressure at room temperature. The obtained hygroscopic crystals of the hydrochloride of 7β-[D-α-(1,4-cyclohexadienyl)- acetylamino]-3-methoxy-3-cephem-4-carboxylic acid are stirred into 200 ml of ice water and the milky solution treated with about 66 ml of cold 2 N sodium hydroxide solution until pH 3.5 is reached. The solution is clarified by filtration through diatomaceous earth, washed with ice water, cooled to 0°C and treated with 20 ml of 2 N sodium hydroxide solution until pH 5.7 is reached. A second filtration through a glass filter frit results in a clear solution which is treated with acetone (800 ml) at 0°C. The crystals are filtered washed with acetone:water (2:1), acetone and diethyl ether and dried for 20 hours at room temperature and 0.05 mm Hg to give the 7β-[D-α-amino-α-(1,4- cyclohexadienyl)-acetylamino]-3-methoxy-3-cephem-4-carboxylic acid dihydrate.

Therapeutic Function

Antibacterial

Antimicrobial activity

Cefroxadine is closely related to cefradine, the structure differing only by the presence of a methoxy group replacing methyl at the C-3 position. The antimicrobial spectrum is identical to that of cefradine and cefalexin. A dose of 1 g as film-coated tablets produced mean peak plasma levels of 25 mg/L at 1 h. Absorption is depressed and delayed by administration with food. The plasma elimination half-life is 0.8 h, rising to 40 h in end-stage renal failure and falling to 3.4 h during hemodialysis. Around 85% of an oral dose is excreted unchanged in the urine. It is available in Japan.

CefroxadineSupplier

XiaoGan ShenYuan ChemPharm co,ltd
Tel
0712-2580635- ;0712-2580635
Email
1791901229@qq.com;1791901229@qq.com;
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725;010-86181995
Email
waley188@sohu.com
Hangzhou Dingyan Chem Co., LTD
Tel
0571-87157530,88025800,86465881
Email
sales@dingyanchem.com
Hefei TNJ Chemical Industry Co.,Ltd.
Tel
0551-65418671
Email
sales@tnjchem.com
Chemwill Asia Co.,Ltd.
Tel
86-21-51086038
Email
chemwill_asia@126.com;sales@chemwill.com;chemwill@hotmail.com;chemwill@gmail.com